Pharmacists in the Oncology Setting: Financial and Clinical Impact is Significant
November 3rd 2022In the inpatient acute care setting, oncology pharmacists maximize return on investments of oncology products, produce optimal outcomes, and ensure that quality of care is consistent and safe.
Read More
Study Links COVID-19 Infection With Elevated Risk of Poor Cardiovascular Health, Death
November 2nd 2022The results showed that these participants were more than 27 times as likely to develop VTE, more than 21.5 times as likely to be diagnosed with heart failure, and 17.5 times as likely to have a stroke.
Read More
Respiratory Syncytial Virus Vaccine Candidate Found to Protect Infants Against Severe Illness
November 2nd 2022Pre-planned safety reviews performed for the duration of the study found that the investigational vaccine is well-tolerated with no safety concerns for both the vaccinated individuals and their newborns.
Read More
Bristol Myers Squibb’s Reblozyl Meets Primary Endpoints as First-Line Treatment of MDS
November 2nd 2022Phase 3 trial evaluated luspatercept-aamt and shows highly statistically significant and clinically meaningful improvement in red blood cell transfusion for those with myelodysplastic syndromes.
Read More